OR WAIT null SECS
Feliza Mirasol is the science editor for Pharmaceutical Technology and Pharmaceutical Technology Europe.
January 02, 2022
There is need for training personnel in various analytical skill sets for biologic drug substance testing.
November 10, 2021
Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.
November 08, 2021
Part 1—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius discuss key issues affecting the development of emerging biotherapies.
November 03, 2021
The increased flow of data from laboratory studies requires a data management strategy to optimize study success.
July 03, 2021
The ever-increasing complexity of biotherapeutic molecules presents unique analytical challenges for developers.
The future pipeline of complex novel biotherapeutics will require new approaches to analytical assessment.